The FDA has approved Daytrana, the first skin patch as an alternative treatment for ADHD in children aged 6-12. It’s designed to be worn for 9 hours (originally submitted to the FDA as a longer-lasting delivery, they were asked to make it shorter), and releases the stimulant methylphenidate.
Comments
This post currently has no comments. You can read the comments or leave your own thoughts on our new comments page.
Trackbacks
Last reviewed: By John M. Grohol, Psy.D. on 7 Apr 2006
Published on PsychCentral.com. All rights reserved.
APA Reference
Kiume, S. (2006). FDA Approves ADHD Patch for Kids. Psych Central. Retrieved on May 25, 2012, from http://psychcentral.com/blog/archives/2006/04/07/fda-approves-adhd-patch-for-kids/
Kiume, S. (2006). FDA Approves ADHD Patch for Kids. Psych Central. Retrieved on May 25, 2012, from http://psychcentral.com/blog/archives/2006/04/07/fda-approves-adhd-patch-for-kids/
